Masashi Nagata

Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS

Yoshihiro Yoshitake, Daiki Fukuma, Akira Yuno et al. · Clinical Cancer Research · 2014 · 153 citations · Full text

Medicine, Immunology, Oncology +17

IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma

Yuichiro Matsuoka, Hideki Nakayama, Ryoji Yoshida et al. · British Journal of Cancer · 2016 · 127 citations · Full text

Medicine, Cancer Biology, Oncology +17

The pathological significance of Notch1 in oral squamous cell carcinoma

Ryoji Yoshida, Masashi Nagata, Hideki Nakayama et al. · Laboratory Investigation · 2013 · 117 citations

Veterinary Medicine, Oncology, Oral Pathology +14

Role of zinc in cellular zinc trafficking and mineralization in a murine osteoblast-like cell line

Masashi Nagata, Bo Lönnerdal · The Journal of Nutritional Biochemistry · 2010 · 108 citations

Medicine, Cell Biology, Physiology +13

Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma

Masashi Nagata, Hideki Nakayama, Takuya Tanaka et al. · British Journal of Cancer · 2011 · 83 citations · Full text

Medicine, Molecular Biology, Oncology +17